knowledge -WSS

knowledge

author：explore 2025-10-01 13:59:08 - browse：2

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： CDC recommends RSV monoclonal antibody for infants

focus

WSS

Florida officials tell state schools to teach AP Psychology 'in its entirety'

A controversial new treatment promises to make little people taller

'Brian's Song' at 50 still offers lessons about cancer for today

Feed a cold, starve a fever? Here’s what science says

Pharma showers House GOP doctor with campaign cash

Restaurant meals are packed with calories, and we still keep eating them

hotspot

knowledge

hotspot

Medical records are filled with copy

CDC recommends RSV monoclonal antibody for infants

New air purifier tech could be key to improving indoor air quality

How CRISPR works, explained in two minutes

Malaria cases in Florida and Texas: Here’s what you need to know

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

At least 13 dead in Texas as scorching temps continue

Judge in Trump's classified documents case questions use of out

Dobbs anniversary: the lost opportunity of abortion as health care

Restaurant meals are packed with calories, and we still keep eating them

focus

Slovenia has suffered its worst

H.R. 3 is the wrong path to lower drug costs

Feed a cold, starve a fever? Here’s what science says

Florida officials tell state schools to teach AP Psychology 'in its entirety'

How CRISPR works, explained in two minutes

FDA approves Sage Therapeutics’ rapid

entertainment

focus

hotspot

hotspot